SEC Form 4 · accession 0001104659-16-129533
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John P Brancaccio
Director
Period of report
Jun 24, 2016
Accepted (ET)
Jun 27, 2016 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.67 | Jun 24, 2016 | A | 62,500 | A | — | Jun 24, 2026 | Common Stock | 62,500 | 421,390 | D |
Explanation of responses
- F120,833 stock options vest on each of 6/24/2017 and 2018 and 20,834 vest on 6/24/2019.